A practical approach for PD-L1 evaluation in gastroesophageal cancer-Reference-Cited by-同舟云学术

A practical approach for PD-L1 evaluation in gastroesophageal cancer

Published:2023-04 Issue:2 Volume:115 Page:57-70
ISSN:1591-951X
Container-title:Pathologica
language:
Short-container-title:Pathologica

Author:

Angerilli Valentina,Fassan Matteo,Parente Paola,Gullo Irene,Campora Michela,Rossi Chiara,Sacramento Maria Luisa,Pennelli Gianmaria,Vanoli Alessandro,Grillo Federica,Mastracci Luca

Publisher

Siapec Servizi Srl

Subject

Pathology and Forensic Medicine

Reference28 articles.

1. Gou Q, Dong C, Xu H, et al. PD-L1 degradation pathway and immunotherapy for cancer. Cell Death Dis 2020;11:955. https://doi.org/10.1038/s41419-020-03140-2

2. Darvin P, Toor SM, Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med 2018;50:1-11. https://doi.org/10.1038/s12276-018-0191-1

3. Booth ME, Smyth EC. Immunotherapy in Gastro-Oesophageal Cancer: Current Practice and the Future of Personalised Therapy. BioDrugs 2022;36:473-485. https://doi.org/10.1007/s40259-022-00527-9

4. Mastracci L, Grillo F, Parente P, et al. PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application. Pathologica 2022;114:352-364. https://doi.org/10.32074/1591-951X-803

5. Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2022;20:167-192. https://doi.org/10.6004/jnccn.2022.0008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in gastrointestinal cancers: Spotlight on the pivotal role of currently available biomarkers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Claudin-18.2 Immunohistochemical Evaluation in Gastric and Gastroesophageal Junction Adenocarcinomas to Direct Targeted Therapy: A Practical Approach;Modern Pathology;2024-11

3. Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study;ESMO Gastrointestinal Oncology;2024-09

4. Best-Practice Biomarker Testing of Oesophago-Gastric Cancer in the UK: Expert Consensus Recommendations Developed Using a Modified Delphi;Clinical Oncology;2024-08

5. CRISPR-Cas-based biosensors for the detection of cancer biomarkers;Analytical Methods;2024